​
​

Aerovate Therapeutics Ownership | Who Owns Aerovate Therapeutics?

OverviewForecastRevenueFinancialsChart

Aerovate Therapeutics Ownership Summary

Aerovate Therapeutics is owned by 97.79% institutional investors, 0.02% insiders, and 2.19% retail investors. Ra capital management is the largest institutional shareholder, holding 33.07% of AVTE shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 1.84% of its assets in Aerovate Therapeutics shares.

AVTE Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockAerovate Therapeutics97.79%0.02%2.19%
SectorHealthcare Stocks 47.06%8.01%44.93%
IndustryBiotech Stocks 44.97%7.82%47.21%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Ra capital management9.19M33.07%$15.26M
Sofinnova investments3.76M13.52%$6.24M
Tcg crossover management2.24M8.06%$3.72M
Atlas venture life science advisors1.80M6.47%$2.99M
Deerfield management company, l.p. (series c)1.41M5.08%$2.34M
Vanguard group1.11M3.98%$1.83M
Blackrock983.06K3.54%$1.63M
Artal group809.60K2.91%$1.34M
Baker bros. advisors lp628.94K2.26%$1.04M
Octagon capital advisors lp465.44K1.67%$772.63K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Tcg crossover management2.24M0.39%$3.72M
Sofinnova investments3.76M0.32%$6.24M
Atlas venture life science advisors1.80M0.31%$2.99M
Ra capital management9.19M0.20%$15.26M
Opaleye management440.00K0.17%$730.40K
Octagon capital advisors lp465.44K0.12%$772.63K
Fifth lane capital, lp50.00K0.12%$83.00K
Nan fung group47.94K0.08%$79.57K
Deerfield management company, l.p. (series c)1.41M0.04%$2.34M
Affinity asset advisors200.00K0.04%$332.00K

Top Buyers

HolderShares% AssetsChange
Deerfield management company, l.p. (series c)1.41M0.04%1.41M
Ra capital management9.19M0.20%928.11K
Artal group809.60K0.03%809.60K
Opaleye management440.00K0.17%440.00K
Vanguard group1.11M-433.01K

Top Sellers

HolderShares% AssetsChange
Frazier life sciences management---1.20M
Cormorant asset management, lp---1.07M
Baker bros. advisors lp628.94K0.01%-1.05M
Great point partners---887.69K
Driehaus capital management---794.99K

New Positions

HolderShares% AssetsChangeValue
Deerfield management company, l.p. (series c)1.41M0.04%1.41M$2.34M
Artal group809.60K0.03%809.60K$1.34M
Opaleye management440.00K0.17%440.00K$730.40K
Verition fund management248.95K0.00%248.95K$413.26K
Affinity asset advisors200.00K0.04%200.00K$332.00K

Sold Out

HolderChange
Nelson, van denburg & campbell wealth management group-2.00
Russell investments group-7.00
Advisor group-69.00
Gamma investing-80.00
Fortitude family office-416.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 20249317.72%27,181,983-4.43%970.93%6255.00%14-39.13%
Mar 31, 20247925.40%28,443,1270.96%1020.89%4029.03%2335.29%
Dec 31, 2023638.62%28,171,582-1.03%1061.01%3129.17%1741.67%
Sep 30, 202358-3.33%28,465,427-0.03%1020.80%24-11.11%12-7.69%
Jun 30, 202360-7.69%28,473,0669.58%1131.03%27-6.90%13-48.00%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv531.54K1.84%-
iShares Russell 2000 ETF450.26K1.56%-1.01K
Vanguard VIF Small Co Gr290.43K1.01%44.85K
Vanguard Institutional Extnd Mkt Idx Tr202.52K0.70%-
State St Russell Sm/Mid Cp® Indx NL Cl C177.39K0.61%-
Fidelity Small Cap Index135.61K0.47%-459.00
iShares Russell 2000 Growth ETF111.78K0.39%-
Fidelity Extended Market Index72.31K0.25%-104.84K
Voya Index Plus SmallCap Port I65.66K0.23%-
Vanguard Russell 2000 ETF61.34K0.21%-374.00

Recent Insider Transactions

DateNameRoleActivityValue
Jun 17, 2024RA CAPITAL MANAGEMENT, L.P. Buy$1.55M
Jun 14, 2024Eldridge George A SEE REMARKSSell$375.45K
Jun 14, 2024Verwijs Marinus CHIEF TECHNICAL OFFICERSell$265.00K
Jun 13, 2024Gillies Hunter CHIEF MEDICAL OFFICERSell$147.00K
May 17, 2024Gillies Hunter CHIEF MEDICAL OFFICERSell$82.45K

Insider Transactions Trends

DateBuySell
2024 Q3--
2024 Q2129
2024 Q1-23
2023 Q4-12
2023 Q3-10

AVTE Ownership FAQ

Who Owns Aerovate Therapeutics?

Aerovate Therapeutics shareholders are primarily institutional investors at 97.79%, followed by 0.02% insiders and 2.19% retail investors. The average institutional ownership in Aerovate Therapeutics's industry, Biotech Stocks , is 44.97%, which Aerovate Therapeutics exceeds.

Who owns the most shares of Aerovate Therapeutics?

Aerovate Therapeutics’s largest shareholders are Ra capital management (9.19M shares, 33.07%), Sofinnova investments (3.76M shares, 13.52%), and Tcg crossover management (2.24M shares, 8.06%). Together, they hold 54.65% of Aerovate Therapeutics’s total shares outstanding.

Does Blackrock own Aerovate Therapeutics?

Yes, BlackRock owns 3.54% of Aerovate Therapeutics, totaling 983.06K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 1.63M$. In the last quarter, BlackRock increased its holdings by 273.31K shares, a 38.51% change.

Who is Aerovate Therapeutics’s biggest shareholder by percentage of total assets invested?

Tcg crossover management is Aerovate Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.39% of its assets in 2.24M Aerovate Therapeutics shares, valued at 3.72M$.

Who is the top mutual fund holder of Aerovate Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Aerovate Therapeutics shares, with 1.84% of its total shares outstanding invested in 531.54K Aerovate Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools